Testing for Sexually Transmitted Diseases in US Public Health Laboratories, 2016.
Testing for Sexually Transmitted Diseases in US Public Health Laboratories, 2016.
复制标题
DOI：
10.1097/olq.0000000000001101
复制
发表时间：
2020-02
影响因子：
3.1
通讯作者：
Gaynor A
中科院分区：
文献类型：
--
作者：
Davis A;Gaynor A
实验室检测做法是性传播疾病(STD)诊断和控制的重要组成部分。本文的目标是描述2016年在美国公共卫生实验室(PHL)进行的性传播疾病检测的数量和类型。2017年5月至8月，共有105名州和地方公共卫生实验室协会成员受邀参加了一项调查。这项基于网络的调查包括针对不同类型的性病提供的检测类型、2016年提供的检测数量以及每种性病检测呈阳性的样品数量。105个成员中有81个(77.1%)有反应。总体而言，2016年在接受调查的实验室进行了2,242,728项沙眼衣原体检测、2,298,596项淋病奈瑟菌(GC)检测、1,235,037项梅毒螺旋体(梅毒)检测、177,571项阴道毛滴虫检测、37,101项单纯疱疹病毒检测和8707项人类乳头瘤病毒检测。67例(82.7%)进行了沙眼衣原体和GC核酸扩增检测。90%的实验室进行了梅毒检测，42%的实验室进行了阴道毛滴虫检测，28.4%的实验室进行了单纯疱疹病毒类型特异性核酸扩增测试。很少有实验室被检测出人类乳头瘤病毒。这项调查收集了有关PHL STD实验室检测实践的重要信息。需要重要参考实验室检测的能力，如GC培养和抗菌药敏感性，以支持STD计划。公共卫生实验室通过提供商业实验室无法提供的检测方法，在性病筛查、监测和预防方面发挥着关键作用。资金限制影响了可用于性病筛查和监测的资源，因此，重要的是继续监测检测做法和公共卫生部门检测性病的能力。
Laboratory testing practices are an important part of sexually transmitted disease (STD) diagnosis and control. The goal of this article is to describe the volume and types of STD tests performed in public health laboratories (PHLs) in the United States in 2016. A total of 105 state and local PHLs who were members of the Association of Public Health Laboratories were invited to participate in a survey between May and August 2017. This web-based survey included questions on types of tests offered for different types of STDs, the number of tests offered in 2016, and number of samples that tested positive for each STD. Eighty-one (77.1%) of 105 member PHLs responded. Overall in 2016, 2,242,728 Chlamydia trachomatis tests, 2,298,596 Neisseria gonorrhoeae (GC) tests, 1,235,037 Treponema pallidum (syphilis) tests, 177,571 Trichomonas vaginalis tests, 37,101 herpes simplex virus tests, and 8707 human papillomavirus tests were performed in 2016 in surveyed laboratories. Sixty-seven (82.7%) of PHLs offered C. trachomatis and GC nucleic acid amplification testing. Ninety percent of laboratories performed syphilis testing, 42% performed T. vaginalis testing, and 28.4% performed herpes simplex virus type–specific nucleic acid amplification testing. Few laboratories tested for human papillomavirus. This survey collected important information on PHL STD laboratory testing practices. Capacity for important reference laboratory testing, such as GC culture and antimicrobial susceptibility, are needed to support STD programs. Public health laboratories play a key role in STD screening, surveillance, and prevention by offering test methods that are not available at commercial laboratories. Funding constraints affect the resources available for STD screening and surveillance, and thus, it is important to continue to monitor testing practices and the capacity of PHLs to test for STDs.